Insta
Zydus Cadila’s COVID-19 Vaccine To be Available Soon For Those In 12-18 Years Age Group: Centre Tells Supreme Court
Zydus
In a positive development, the Government yesterday (26 June) informed the Supreme Court that Ahmedabad-based Zydus Cadila's new COVID-19 vaccine will soon be available for those in the age group of 12-18 years, reports Livemint.
The Government also told the court that while Covishield, Covaxin and Sputnik V are being used to inoculate the population presently, more domestic vaccines such as those from Zydus Cadila and Hyderabad-based biological E are in the late stages of clinical trials and subject to regulatory approvals, will further increase the availability of vaccines.
The government also informed the top court that the production capacity of COVID-19 vaccines in the country is being ramped up and that the supply is expected to further increase in the next few months.
The Government also said, "As per the projected midyear population for 2020, the total population of the country aged 18 years and above is approximately 93-94 crore and as such, administering two doses to these beneficiaries would require an estimated 186 to 188 crore vaccine doses."
Support Swarajya's 50 Ground Reports Project & Sponsor A Story
Every general election Swarajya does a 50 ground reports project.
Aimed only at serious readers and those who appreciate the nuances of political undercurrents, the project provides a sense of India's electoral landscape. As you know, these reports are produced after considerable investment of travel, time and effort on the ground.
This time too we've kicked off the project in style and have covered over 30 constituencies already. If you're someone who appreciates such work and have enjoyed our coverage please consider sponsoring a ground report for just Rs 2999 to Rs 19,999 - it goes a long way in helping us produce more quality reportage.
You can also back this project by becoming a subscriber for as little as Rs 999 - so do click on this links and choose a plan that suits you and back us.
Click below to contribute.
Latest
